| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.03 |